<--- Back to Details
First PageDocument Content
Muscular dystrophy / Cytoskeleton / Dystrophin / Pharmaceutical industry / Conflict of interest / National Institutes of Health / Biology / Medicine / Health
Muscular dystrophy
Cytoskeleton
Dystrophin
Pharmaceutical industry
Conflict of interest
National Institutes of Health
Biology
Medicine
Health

Disclosure Form: Rabi Tawil

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 44,46 KB

Share Document on Facebook

Similar Documents

CLIENT PROGRAMS MEET OUR NEW WORKING WHEELS TEAM At the end of last year I was diagnosed with limb-girdle muscular dystrophy. Through Working Wheels (WW)

DocID: 1uWBv - View Document

ZOMBIE FACT #1 CIRCLES Muscular dystrophy, hemiplegia, even complete loss of limbs are common in zombies. The sum of these things means that zombies often end up shambling around in circles. This puzzle requires site sp

DocID: 1uPJ4 - View Document

Microsoft Word - ASX 17_ 2 October_ ATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update summary_Final

DocID: 1ulfx - View Document

19 DecemberATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update Antisense Therapeutics Limited (“ANP” or “the Company”) provides the following update on the progress of its Multiple Sclero

DocID: 1tPwS - View Document

Links to Equipment Funding Sources   Muscular Dystrophy Family Foundation (not associated with MDA) -- http://mdff.org/  -- Its mission is to provide adaptive equipment and emotional support to individuals and familie

DocID: 1tfNF - View Document